Month: October 2017
What’s the Stem Cells Buzz this Week? – Distal Limb Wound Healing, Dentin-Pulp Tissue Regeneration, Report from the ISCBI, and MSCs Requirement for Survivin!

What’s the Stem Cells Buzz this Week? – Distal Limb Wound Healing, Dentin-Pulp Tissue Regeneration, Report from the ISCBI, and MSCs Requirement for Survivin!

The Stem Cells Portal brings you a roundup of some of the new and exciting stories in the ever-changing world of stem cells, regenerative medicine, and beyond! MSC-mediated Healing of Distal Limb Wounds Both humans and horses may benefit from allogeneic mesenchymal stem cell (MSC) therapy for distal extremity wounds. To assess the potential benefits …

What’s the Stem Cells Buzz this Week? – MSC Therapy for BD, Wnt Signaling in Skin Development and Epidermal SCs, miRNAs Inhibit HSC Formation, and an In Vivo Osteogenesis Showdown!

What’s the Stem Cells Buzz this Week? – MSC Therapy for BD, Wnt Signaling in Skin Development and Epidermal SCs, miRNAs Inhibit HSC Formation, and an In Vivo Osteogenesis Showdown!

The Stem Cells Portal brings you a roundup of some of the new and exciting stories in the ever-changing world of stem cells, regenerative medicine, and beyond! MSC Therapy in Bronchopulmonary Dysplasia Extreme premature birth in children often leads to bronchopulmonary dysplasia (BPD), and while animal models suggest that mesenchymal stromal cell (MSC) therapy can …

What’s the Stem Cells Buzz this Week? – Single-Cell SSPCs Analysis, Treg-mediated Cancer Cell Stemness, Parthenogenetic ESC-derived Cortical Neurons, and Protection of Retinal Ganglion Cells!

What’s the Stem Cells Buzz this Week? – Single-Cell SSPCs Analysis, Treg-mediated Cancer Cell Stemness, Parthenogenetic ESC-derived Cortical Neurons, and Protection of Retinal Ganglion Cells!

The Stem Cells Portal brings you a roundup of some of the new and exciting stories in the ever-changing world of stem cells, regenerative medicine, and beyond! Identifying SSPCs with Single-Cell RNA-Seq A recent study from the laboratory of Bart Deplancke (Ecole Polytechnique Fédérale de Lausanne and Swiss Institute of Bioinformatics, Lausanne, Switzerland) has applied …

What’s the Stem Cells Buzz this Week? – CAR T Cell Therapies, Intestinal Stem Cell Fitness, Alveolar Injury treatment with EPCs, and iPSC Neuropsychiatric Disease Models!

What’s the Stem Cells Buzz this Week? – CAR T Cell Therapies, Intestinal Stem Cell Fitness, Alveolar Injury treatment with EPCs, and iPSC Neuropsychiatric Disease Models!

The Stem Cells Portal brings you a roundup of some of the new and exciting stories in the ever-changing world of stem cells, regenerative medicine, and beyond! Lessons Learned from CAR T cell Therapies for B Cell Malignancies Soon to be approved chimeric antigen receptor T (CAR T) cell therapies for B cell malignancies in pediatric …

What’s the Stem Cells Buzz this Week? – Enhanced RGC Generation, Bladder Tissue Engineering, Placental MSC-Treatment of Cardiomyopathy, and MSC-EVs Enhance Survival after Irradiation!

What’s the Stem Cells Buzz this Week? – Enhanced RGC Generation, Bladder Tissue Engineering, Placental MSC-Treatment of Cardiomyopathy, and MSC-EVs Enhance Survival after Irradiation!

The Stem Cells Portal brings you a roundup of some of the new and exciting stories in the ever-changing world of stem cells, regenerative medicine, and beyond! Enhanced Generation of Human Retinal Ganglion Cells A new report from the labs of Donald J. Zack (Johns Hopkins University School of Medicine, Maryland, USA) and Derek S. …

What’s the Stem Cells Buzz this Week? – Naming MSCs, NHIE Cell Therapy, mESCs go “Surfen”, and Promoting Tendon Differentiation with Fos!

What’s the Stem Cells Buzz this Week? – Naming MSCs, NHIE Cell Therapy, mESCs go “Surfen”, and Promoting Tendon Differentiation with Fos!

The Stem Cells Portal brings you a roundup of some of the new and exciting stories in the ever-changing world of stem cells, regenerative medicine, and beyond! Naming MSCs – The Battle Goes on! A recent STEM CELLS Translational Medicine Perspective laid out the claim for mesenchymal stem cells (MSCs) to be renamed “medicinal signaling cells”, …

$20 million granted for clinical trial of stem cell therapy for high-risk type 1 diabetes

$20 million granted for clinical trial of stem cell therapy for high-risk type 1 diabetes

ViaCyte Inc., a privately held regenerative medicine company, has been awarded a $20 million grant from the California Institute for Regenerative Medicine (CIRM) to support the clinical development of its PEC-Direct™ product candidate.  This novel cell replacement therapy is being developed as a functional cure for patients with type 1 diabetes who are at high …

What’s the Stem Cells Buzz this Week? – Endometrial Regenerative Cells, Paralogous Bone Marrow Niche Model, ONS Cell Conduits, and Transplanted Fetal Liver Progenitor Cell Fate!

What’s the Stem Cells Buzz this Week? – Endometrial Regenerative Cells, Paralogous Bone Marrow Niche Model, ONS Cell Conduits, and Transplanted Fetal Liver Progenitor Cell Fate!

The Stem Cells Portal brings you a roundup of some of the new and exciting stories in the ever-changing world of stem cells, regenerative medicine, and beyond! ERCs Induce Cardiac Allograft Tolerance Studies have demonstrated the therapeutic potential of mesenchymal-like endometrial regenerative cells (ERCs) in various disease models, and now, new research from Hao Wang …

Investigating Adipose-derived Cells as a Treatment for Multiple Sclerosis

Investigating Adipose-derived Cells as a Treatment for Multiple Sclerosis

Review of “Immunomodulatory Effects of Adipose Stromal Vascular Fraction Cells Promote Alternative Activation Macrophages to Repair Tissue Damage” from STEM CELLS by Stuart P. Atkinson Autoimmune responses in the peripheral lymphoid tissues against the protein sheath that insulates nerve axons in the central nervous system (CNS) leads to the unfortunately common neurodegenerative disease Multiple Sclerosis …

Contact Us